top of page
ARVO 2026: NEXT GENERATION RETINA THERAPEUTICS AND ADVANCES IN AI SHOWCASE
Moderators: Allen C. Ho, MD and Srinivas Sadda, MD,
Panel: Mark Humayun, MD, PhD and Anat Loewenstein, MD, MHA
Room: 405
Start | Company | Presenter |
|---|---|---|
1:30 PM | Introduction | Srinivas Sadda, MD |
1:31 PM | Ripple Therapeutics | Tom Reeves, Co-Founder, President & CEO |
1:36 PM | Kanaph Therapeutics | Wai T. Wong, MD, PhD, Co-Founder, President & CEO |
1:41 PM | OD-OS MacuTherm | Jan Tode, MD, Chief Medical Officer |
1:46 PM | Discussion | |
1:51 PM | Alkeus Pharmaceuticals | Michel Dahan, President & CEO |
1:56 PM | Octant | Matthew L. Albert, MD PhD, VP, Discovery Biology & Early Clinical Development |
2:01 PM | Discussion | |
2:04 PM | Neuvasq Biotechnologies | Ralph Laufer, PhD, Chief Scientific Officer |
2:09 PM | Surrozen | Daniel L. Chao, MD, PhD, VP, Head of Clinical Development |
2:14 PM | Oculis | Riad Sherif, MD, CEO |
2:19 PM | Discussion |
Anchor 1
bottom of page
